ConductScience.org, home

Paper4606174

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

Jaffe N and 3 others. N Engl J Med, 1974. Cited by 540 papers, by iCite.

Cite this record

ConductScience Library. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. Papers, record 4606174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4606174

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
PubMed
Journal
N Engl J Med
PubMed
Year
1974
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
540
iCite
Relative citation ratio, by iCite
16.1
iCite
Revised in PubMed
2022-12-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jaffe NN
2Frei E 3rdE
3Traggis DD
4Bishop YY

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone NeoplasmsMajor topic
LeucovorinMajor topic
MethotrexateMajor topic
OsteosarcomaMajor topic
Amputation, Surgical
Clinical Trials as Topic
Drug Therapy, Combination
Femoral Neoplasms
Follow-Up Studies
Humans
Injections, Intramuscular
Injections, Intravenous
Lung Neoplasms
Neoplasm Metastasis
Time Factors
Vincristine

Source PubMed

Download CSV of topics

Cited by78

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 540 citations.

PMIDTitleJournalYearIn PapersSource
40442778Targeting metastasis in paediatric bone sarcomas.Mol Cancer2025https://conductscience.org/library/papers/40442778PubMed
40336661Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning.Drug Des Devel Ther2025https://conductscience.org/library/papers/40336661PubMed
40206491Post-treatment late and long-term effects in bone sarcoma: A scoping review.J Bone Oncol2025https://conductscience.org/library/papers/40206491PubMed
39941818Analysis and Historical Evolution of Paediatric Bone Tumours: The Importance of Early Diagnosis in the Detection of Childhood Skeletal Malignancies.Cancers (Basel)2025https://conductscience.org/library/papers/39941818PubMed
38404899Bulk and single-cell sequencing identified a prognostic model based on the macrophage and lipid metabolism related signatures for osteosarcoma patients.Heliyon2024https://conductscience.org/library/papers/38404899PubMed
37505768Total Neoadjuvant vs. Standard Perioperative Cisplatin/ Doxorubicin Chemotherapy in Patients with Extremities Osteosarcoma: A Multi-Center Cohort Study.Asian Pac J Cancer Prev2023https://conductscience.org/library/papers/37505768PubMed
37460542Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma.Cell Death Dis2023https://conductscience.org/library/papers/37460542PubMed
36900310Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS).Cancers (Basel)2023https://conductscience.org/library/papers/36900310PubMed
36814318Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.J Orthop Surg Res2023https://conductscience.org/library/papers/36814318PubMed
36803784P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization.J Transl Med2023https://conductscience.org/library/papers/36803784PubMed
35163459Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy.Int J Mol Sci2022https://conductscience.org/library/papers/35163459PubMed
33082842Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.Comput Math Methods Med2020https://conductscience.org/library/papers/33082842PubMed
32961800Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.Int J Mol Sci2020https://conductscience.org/library/papers/32961800PubMed
32483726Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective.Adv Exp Med Biol2020https://conductscience.org/library/papers/32483726PubMed
32063749Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma.Cancer Cell Int2020https://conductscience.org/library/papers/32063749PubMed
31446435The Roles of Circular RNAs in Osteosarcoma.Med Sci Monit2019https://conductscience.org/library/papers/31446435PubMed
31083238Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation.Medicine (Baltimore)2019https://conductscience.org/library/papers/31083238PubMed
30732148Integrative analysis reveals driver long non-coding RNAs in osteosarcoma.Medicine (Baltimore)2019https://conductscience.org/library/papers/30732148PubMed
30483135Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.Front Pharmacol2018https://conductscience.org/library/papers/30483135PubMed
30378256A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.Pediatr Blood Cancer2019https://conductscience.org/library/papers/30378256PubMed

See all 78 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4606174

GET https://conductscience.org/api/papers/v1/4606174/cited_by?page=2